Clone-censor weighting and dementia risk after statin initiation in diabetes: when the analyzed population is no longer the observed population

We read with interest the report by Ternhamar and colleagues about lower dementia risk with earlier statin initiation after diagnosis of type 2 diabetes in statin-naïve individuals.1 The authors should be commended for addressing one of the fundamental issues of observational studies, the prevalent-user bias, with the use of a new-user design. We highlight a less apparent issue for clinicians: the transition from real patients to cloned synthetic patients.

Authors

Institutions

Publication Details

Journal
The Lancet Regional Health - Europe
Published
2026-11-14
DOI
https://doi.org/10.1016/j.lanepe.2026.101927
Citations
1
Primary Topic
Statistical Methods in Epidemiology
Type
article
Field-Weighted Citation Impact
1.46

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Clone-censor weighting and dementia risk after statin initiation in diabetes: when the analyzed population is no longer the observed population

Ali Ahmed, Michael Böhm, Andrew J. S. Coats, Gregg C. Fonarow et al.
1 citations
The Lancet Regional Health - Europe
Statistical Methods in Epidemiology
1.46
article

Clone-censor weighting and dementia risk after statin initiation in diabetes: when the analyzed population is no longer the observed population

Ali Ahmed, Michael Böhm, Andrew J. S. Coats, Gregg C. Fonarow, Stefan D. Anker, John G.F. Cleland
article en
1 citations

Abstract

We read with interest the report by Ternhamar and colleagues about lower dementia risk with earlier statin initiation after diagnosis of type 2 diabetes in statin-naïve individuals.1 The authors should be commended for addressing one of the fundamental issues of observational studies, the prevalent-user bias, with the use of a new-user design. We highlight a less apparent issue for clinicians: the transition from real patients to cloned synthetic patients.

The Lancet Regional Health - EuropeVol. 71
University of California, Los Angeles (US), Georgetown University (US), George Washington University (US), Veterans Health Administration (US), The Heart Research Institute (AU), German Centre for Cardiovascular Research (DE), Washington DC VA Medical Center (US), Charité - Universitätsmedizin Berlin (DE), University of Glasgow (GB), Saarland University (DE)
U.S. Department of Veterans Affairs, National Institute on Aging
Good health and well-being
Openalex Percentile: Top 24%
Statistical Methods in Epidemiology
1.46
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Clone-censor weighting and dementia risk after statin initiation in diabetes: when the analyzed population is no longer the observed population — Ali Ahmed, Michael Böhm, et al. · The Lancet Regional Health - Europe (2026) | TGRS Research Map | TGRS